Medicinova (MNOV) Current Taxes (2010 - 2012)
Medicinova's (MNOV) quarterly Current Taxes came in at $1084.0 in Q1 2012, down 83.3% on a QoQ basis from $6490.0 in Q4 2011.
Medicinova (MNOV) Current Taxes (2010 - 2012) Analysis & Trends
Medicinova (MNOV) has 3 years of Current Taxes data on file, last reported at $1084.0 in Q1 2012.
- On a quarterly basis, Current Taxes changed N/A year-over-year to $1084.0 in Q1 2012; TTM through Mar 2012 was $1084.0, a N/A change from a year earlier, with the FY2011 full-year figure at $6490.0, down 5.21% from the prior year.
- Current Taxes for Q1 2012 stood at $1084.0, down from $6490.0 in the prior quarter.
- Over the last five years, Current Taxes for MNOV reached as high as $6847.0 in Q4 2010 and fell as low as $1084.0 in Q1 2012.
- Historically, Current Taxes has averaged $3950.0 across 3 years, with a median of $3934.5 in 2011.
- On a YoY basis, Current Taxes climbed as much as 5.21% in 2011 and fell as far as 5.21% in 2011.
- Year by year, Current Taxes stood at $6847.0 in 2010, then slipped by 5.21% to $6490.0 in 2011, then plunged by 83.3% to $1084.0 in 2012.
- Per Business Quant data, the three most recent Current Taxes figures were $1084.0 in Q1 2012, $6490.0 in Q4 2011, and $1379.0 in Q2 2011.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 63.52 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 49.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Medicinova | 64.48 Mn | 64.48 Mn | 4,754.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2012 | 1,084.00 |
| Dec 31, 2011 | 6,490.00 |
| Jun 30, 2011 | 1,379.00 |
| Dec 31, 2010 | 6,847.00 |